• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲对当前慢性便秘治疗选择的满意度水平——一项互联网调查。

Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey.

机构信息

Department of Internal Medicine, Park-Klinik Weissensee, Berlin, Germany.

出版信息

Aliment Pharmacol Ther. 2013 Jan;37(1):137-45. doi: 10.1111/apt.12124. Epub 2012 Nov 5.

DOI:10.1111/apt.12124
PMID:23126338
Abstract

BACKGROUND

Data on treatment satisfaction in European men and women with chronic constipation are limited.

AIM

To assess satisfaction with current treatment among European men and women with chronic constipation.

METHODS

An internet-based survey was conducted in 2009 in 10 European countries: Austria, Germany, France, Ireland, Italy, Spain, Switzerland, the UK, Belgium and the Netherlands. Participants had self-reported chronic constipation (<3 bowel movements/week and ≥1 symptoms for ≥6 months of: pain during defecation; lumpy/hard faeces; and feeling of incomplete evacuation). Demographic data and disease history were collected. For participants using laxatives, drug name/class, satisfaction with treatment and interest in other treatments were collected.

RESULTS

Of the 1941 participants screened, 1355 had chronic constipation and met the inclusion criteria (chronic constipation population). The majority of the chronic constipation population who disclosed their sex (n = 811) were women (82%). Sixty-eight per cent of respondents (n = 855/1255) reported using laxatives, with the proportion of laxative users differing between subsets. Twenty-eight per cent (n = 225/793) were (very) satisfied with their treatment, whereas 44% (n = 345/793) were neutral and 28% (n = 223/793) (very) dissatisfied. There was no relationship between type of laxative and degree of (dis)satisfaction. Interest in other treatments was high with 83% (n = 686/827) of respondents 'absolutely' or 'probably' interested. Respondents dissatisfied with their treatment were more likely to be interested in other treatments.

CONCLUSIONS

Laxative-use is common for chronic constipation. In this large survey, 28% of participants were dissatisfied with their treatment, with the majority interested in other treatments.

摘要

背景

欧洲慢性便秘患者的治疗满意度数据有限。

目的

评估欧洲慢性便秘患者对当前治疗的满意度。

方法

2009 年在 10 个欧洲国家(奥地利、德国、法国、爱尔兰、意大利、西班牙、瑞士、英国、比利时和荷兰)进行了一项基于互联网的调查。参与者自我报告患有慢性便秘(<3 次/周排便,≥6 个月存在以下 1 项或多项症状:排便时疼痛;块状/硬粪便;排便不净感)。收集了人口统计学数据和疾病史。对于使用泻药的参与者,收集了药物名称/类别、治疗满意度和对其他治疗方法的兴趣。

结果

在筛选的 1941 名参与者中,有 1355 名患有慢性便秘并符合纳入标准(慢性便秘人群)。公开性别的慢性便秘人群中(n=811),女性占多数(82%)。68%(n=855/1255)的受访者报告使用了泻药,不同亚组的泻药使用者比例不同。28%(n=225/793)的人(非常)满意他们的治疗,而 44%(n=345/793)的人持中立态度,28%(n=223/793)的人(非常)不满意。泻药类型与(不)满意度之间没有关系。对其他治疗方法的兴趣很高,83%(n=686/827)的受访者表示“绝对”或“可能”感兴趣。对治疗不满意的受访者更有可能对其他治疗方法感兴趣。

结论

慢性便秘常使用泻药治疗。在这项大型调查中,28%的参与者对他们的治疗不满意,大多数人对其他治疗方法感兴趣。

相似文献

1
Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey.欧洲对当前慢性便秘治疗选择的满意度水平——一项互联网调查。
Aliment Pharmacol Ther. 2013 Jan;37(1):137-45. doi: 10.1111/apt.12124. Epub 2012 Nov 5.
2
[Laxative use and satisfaction of chronically constipated women - a survey of female patients and gastroenterologists in Germany].[长期便秘女性的泻药使用情况与满意度——德国女性患者及胃肠病学家的一项调查]
Z Gastroenterol. 2012 Jun;50(6):573-7. doi: 10.1055/s-0031-1299133. Epub 2012 Jun 1.
3
Factors affecting satisfaction with treatment in European women with chronic constipation: An internet survey.影响欧洲慢性便秘女性治疗满意度的因素:一项网络调查。
United European Gastroenterol J. 2013 Oct;1(5):375-84. doi: 10.1177/2050640613494200.
4
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.普芦卡必利(Resolor)用于治疗对泻药不满意的重度慢性便秘患者。
Gut. 2009 Mar;58(3):357-65. doi: 10.1136/gut.2008.162404. Epub 2008 Nov 5.
5
A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation.一项针对自我认定患有便秘的成年人泻药使用情况及模式的多国调查。
Aliment Pharmacol Ther. 2008 Oct 1;28(7):917-30. doi: 10.1111/j.1365-2036.2008.03806.x. Epub 2008 Jul 17.
6
Psychometric development and validation of the chronic constipation treatment satisfaction questionnaire (CTSAT-Q).慢性便秘治疗满意度问卷(CTSAT-Q)的心理测量学发展与验证
Value Health. 2009 Sep;12(6):1004-10. doi: 10.1111/j.1524-4733.2009.00533.x. Epub 2009 Mar 11.
7
Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.临床试验:普芦卡必利开放性治疗慢性便秘患者的疗效 - 关键性研究中患者的随访。
Aliment Pharmacol Ther. 2010 Nov;32(9):1113-23. doi: 10.1111/j.1365-2036.2010.04455.x. Epub 2010 Sep 16.
8
Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.临床试验:普芦卡必利治疗严重慢性便秘的疗效、对生活质量的影响以及安全性和耐受性——一项为期12周的随机双盲安慰剂对照研究。
Aliment Pharmacol Ther. 2009 Feb 1;29(3):315-28. doi: 10.1111/j.1365-2036.2008.03884.x. Epub 2008 Nov 8.
9
Opioid-induced constipation, use of laxatives, and health-related quality of life.阿片类药物引起的便秘、泻药的使用与健康相关生活质量
Scand J Pain. 2016 Apr;11:104-110. doi: 10.1016/j.sjpain.2015.12.007. Epub 2016 Jan 25.
10
The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use.在使用足够泻药的慢性疼痛患者中,阿片类药物引起便秘的影响。
Int J Clin Pract. 2015 Dec;69(12):1448-56. doi: 10.1111/ijcp.12718. Epub 2015 Sep 6.

引用本文的文献

1
The metabolic pathway of Deg-AZM and investigations into the contribution of drug metabolizing enzymes and drug transporters in the drug interactions of Deg-AZM, a clinical-stage new transgelin agonist.Deg-AZM的代谢途径以及对药物代谢酶和药物转运体在Deg-AZM(一种临床阶段的新型反式凝胶蛋白激动剂)药物相互作用中所起作用的研究。
Front Pharmacol. 2025 Jan 8;15:1510903. doi: 10.3389/fphar.2024.1510903. eCollection 2024.
2
Prevalence and patterns of laxative use in subjects with self-reported constipation: results from a multinational digestive health survey.自我报告有便秘症状的受试者中泻药使用的患病率及模式:一项多国消化健康调查的结果
Therap Adv Gastroenterol. 2024 Mar 4;17:17562848241232605. doi: 10.1177/17562848241232605. eCollection 2024.
3
Vibrating colon-stimulating capsule to treat chronic constipation: A systematic review.振动结肠刺激胶囊治疗慢性便秘:系统评价。
J Med Life. 2023 Jul;16(7):1050-1056. doi: 10.25122/jml-2023-1025.
4
Intermittent colonic exoperistalsis for chronic constipation in spinal cord-injured individuals. A long-term structured patient feedback survey to evaluate home care use.脊髓损伤患者慢性便秘的间歇性结肠外蠕动。长期结构化的患者反馈调查,以评估家庭护理的使用情况。
Spinal Cord Ser Cases. 2023 Jul 29;9(1):37. doi: 10.1038/s41394-023-00597-z.
5
Perceptions of and Practices for the Management of Constipation: Results of a Korean National Survey.对便秘管理的认知和实践:一项韩国全国性调查的结果。
Gut Liver. 2024 Mar 15;18(2):275-282. doi: 10.5009/gnl230062. Epub 2023 Jul 17.
6
Interferential therapy for chronic constipation in adults: The CON-COUR randomizedcontrolled trial.成人慢性便秘的干扰电疗法:CON-COUR随机对照试验
United European Gastroenterol J. 2023 Apr 25;11(4):337-49. doi: 10.1002/ueg2.12373.
7
Safety and Efficacy of Elobixibat, an Ileal Bile Acid Transporter Inhibitor, in Elderly Patients With Chronic Idiopathic Constipation According to Administration Time: Interim Analysis of Post-marketing Surveillance.回肠胆汁酸转运体抑制剂依洛比昔巴特在老年慢性特发性便秘患者中根据给药时间的安全性和有效性:上市后监测的中期分析
J Neurogastroenterol Motil. 2022 Jul 30;28(3):431-441. doi: 10.5056/jnm20263.
8
Effects of P9 Probiotics on Defecation and Quality of Life of Individuals with Chronic Constipation: Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.P9益生菌对慢性便秘患者排便及生活质量的影响:一项随机、双盲、安慰剂对照临床试验方案
Evid Based Complement Alternat Med. 2022 Jun 13;2022:4144321. doi: 10.1155/2022/4144321. eCollection 2022.
9
A Shigella species variant is causally linked to intractable functional constipation.志贺氏菌属的一个菌种变异与难治性功能性便秘有关。
J Clin Invest. 2022 Jul 15;132(14). doi: 10.1172/JCI150097.
10
Comparison of therapeutic effects of different acupuncture and moxibustion therapies on constipation after stroke treatment: A protocol for systematic review and network meta-analysis.不同针灸疗法治疗中风后便秘的疗效比较:系统评价和网络荟萃分析方案。
Medicine (Baltimore). 2021 Oct 15;100(41):e27397. doi: 10.1097/MD.0000000000027397.